Publication:
The True Story and Advantages of RNA Phage Capsids as Nanotools.

cris.virtualsource.author-orcid09b183c2-572b-41f7-9f2c-e731dd0c1430
datacite.rightsopen.access
dc.contributor.authorPumpens, Paul
dc.contributor.authorRenhofa, Regina
dc.contributor.authorDishlers, Andris
dc.contributor.authorKozlovska, Tatjana
dc.contributor.authorOse, Velta
dc.contributor.authorPushko, Peter
dc.contributor.authorTars, Kaspars
dc.contributor.authorGrens, Elmars
dc.contributor.authorBachmann, Martin
dc.date.accessioned2024-10-24T19:18:23Z
dc.date.available2024-10-24T19:18:23Z
dc.date.issued2016
dc.description.abstractRNA phages are often used as prototypes for modern recombinant virus-like particle (VLP) technologies. Icosahedral RNA phage VLPs can be formed from coat proteins (CPs) and are efficiently produced in bacteria and yeast. Both genetic fusion and chemical coupling have been successfully used for the production of numerous chimeras based on RNA phage VLPs. In this review, we describe advances in RNA phage VLP technology along with the history of the Leviviridae family, including its taxonomical organization, genomic structure, and important role in the development of molecular biology. Comparative 3D structures of different RNA phage VLPs are used to explain the level of VLP tolerance to foreign elements displayed on VLP surfaces. We also summarize data that demonstrate the ability of CPs to tolerate different organic (peptides, oligonucleotides, and carbohydrates) and inorganic (metal ions) compounds either chemically coupled or noncovalently added to the outer and/or inner surfaces of VLPs. Finally, we present lists of nanotechnological RNA phage VLP applications, such as experimental vaccines constructed by genetic fusion and chemical coupling methodologies, nanocontainers for targeted drug delivery, and bioimaging tools.
dc.description.numberOfPages37
dc.description.sponsorshipUniversitätsklinik für Rheumatologie, Immunologie und Allergologie, Fachbereich Immunologie
dc.identifier.doi10.7892/boris.94914
dc.identifier.pmid27829245
dc.identifier.publisherDOI10.1159/000449503
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/149459
dc.language.isoen
dc.publisherKarger
dc.relation.ispartofIntervirology
dc.relation.issn0300-5526
dc.relation.organizationDCD5A442BA48E17DE0405C82790C4DE2
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleThe True Story and Advantages of RNA Phage Capsids as Nanotools.
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.endPage110
oaire.citation.issue2
oaire.citation.startPage74
oaire.citation.volume59
oairecerif.author.affiliationUniversitätsklinik für Rheumatologie, Immunologie und Allergologie, Fachbereich Immunologie
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.embargoChanged2017-11-11 01:30:03
unibe.description.ispublishedpub
unibe.eprints.legacyId94914
unibe.refereedtrue
unibe.subtype.articlereview

Files

Original bundle
Now showing 1 - 1 of 1
Name:
449503.pdf
Size:
949.32 KB
Format:
Adobe Portable Document Format
File Type:
text
License:
publisher
Content:
published

Collections